Gadolinium contrast may be risky in kidney disease

BMJ. 2007 Jun 30;334(7608):1335-6. doi: 10.1136/bmj.39254.924641.1F.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Contrast Media / adverse effects*
  • Fibromyalgia / chemically induced
  • Gadolinium / adverse effects*
  • Gadolinium DTPA / adverse effects
  • Humans
  • Kidney Diseases / chemically induced*
  • Magnetic Resonance Angiography / standards
  • Organometallic Compounds / adverse effects
  • Peripheral Vascular Diseases / diagnosis*
  • Risk Factors

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadodiamide
  • Gadolinium
  • Gadolinium DTPA
  • gadoversetamide